Boenning & Scattergood’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
RCM
SCM
RJA
AC
AW
Boenning & Scattergood's BCAT Position: Q4 2022 in Review
Boenning & Scattergood sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q4 2022, closing a stake of 16,000 shares — an estimated $218K sold.
Boenning & Scattergood first reported a position in BCAT in Q3 2022 and held it in 1 quarter. The position peaked at $218K in Q3 2022. 85 funds tracked by Wall St. Rank hold BCAT as of Q4 2022.
- Boenning & Scattergood reported no remaining BlackRock Capital Allocation Term Trust position as of Q4 2022 after selling out during the quarter.
- Boenning & Scattergood sold 16,000 BlackRock Capital Allocation Term Trust shares in Q4 2022, an estimated $218K.
- Boenning & Scattergood first reported a position in BlackRock Capital Allocation Term Trust in Q3 2022 and held it in 1 quarter.
- Boenning & Scattergood's BlackRock Capital Allocation Term Trust position peaked at $218K in Q3 2022.
- 85 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q4 2022.
Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.